Compound patented by SFA’s National Center for Pharmaceutical Crops Shows Promise in Treating Cancer

by Sarah Fuller Outreach coordinator at SFASU Arthur Temple College of Forestry and Agriculture
This content is for subscribers only. Log in or sign up for a free trial below.

A team of researchers, including Dr. Shiyou Li, pictured, research professor and director of the National Center for Pharmaceutical Crops at Stephen F. Austin State University, recently received a U.S. patent for Salvinol, a compound derived from the invasive giant salvinia plant. Lab trials conducted at the NCPC show Salvinol can slow and, in some cases, completely inhibit the growth of a wide range of cancer cells, including pancreatic and lung cancer cells.